IFAM
DNTH icon

Institutional & Family Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Institutional & Family Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$78 Hold
3
– – ﹤0.01% 738
2024
Q1 		$90 Hold
3
– – ﹤0.01% 725
2023
Q4 		$31 Hold
3
– – ﹤0.01% 706
2023
Q3 		$41 Hold
3
– – ﹤0.01% 707
2023
Q2 		$38 Hold
3
– – ﹤0.01% 749
2023
Q1 		$40 Hold
3
– – ﹤0.01% 725
2022
Q4 		$20 Hold
3
– – ﹤0.01% 716
2022
Q3 		$0 Hold
3
– – ﹤0.01% 720
2022
Q2 		$0 Hold
3
– – ﹤0.01% 738
2022
Q1 		$0 Hold
3
– – ﹤0.01% 790
2021
Q4 		$0 Hold
3
– – ﹤0.01% 832
2021
Q3 		$0 Hold
3
– – ﹤0.01% 921
2021
Q2 		$0 Hold
3
– – ﹤0.01% 959
2021
Q1 		$1K Hold
3
– – ﹤0.01% 855
2020
Q4 		$0 Hold
3
– – ﹤0.01% 873
2020
Q3 		$0 Buy
+3
New +$355 ﹤0.01% 845

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Institutional & Family Asset Management's DNTH Position: Q2 2024 in Review

Institutional & Family Asset Management held its Dianthus Therapeutics (DNTH) position steady in Q2 2024 at 3 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Institutional & Family Asset Management first reported a position in DNTH in Q3 2020 and has held it in 16 quarters since. The position peaked at $1K in Q1 2021. 74 funds tracked by Wall St. Rank hold DNTH as of Q2 2024.

  • Institutional & Family Asset Management held 3 shares of Dianthus Therapeutics worth $78 as of Q2 2024.
  • Institutional & Family Asset Management left its Dianthus Therapeutics share count unchanged in Q2 2024.
  • Dianthus Therapeutics made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #738 holding.
  • Institutional & Family Asset Management first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 16 quarters since.
  • Institutional & Family Asset Management's Dianthus Therapeutics position peaked at $1K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.